Invizyne Technologies Inc... (IZTC)
NASDAQ: IZTC
· Real-Time Price · USD
16.50
1.00 (6.45%)
At close: Feb 11, 2025, 3:59 PM
6.45% (1D)
Bid | 13.06 |
Market Cap | 157.23M |
Revenue (ttm) | n/a |
Net Income (ttm) | n/a |
EPS (ttm) | -0.63 |
PE Ratio (ttm) | -26.19047619047619 |
Forward PE | n/a |
Analyst | n/a |
Ask | 18.5 |
Volume | 12,043 |
Avg. Volume (20D) | 37,034 |
Open | 15.17 |
Previous Close | 15.50 |
Day's Range | 15.17 - 17.00 |
52-Week Range | 8.50 - 23.99 |
Beta | -4.51 |
About IZTC
Invizyne Technologies, Inc. operates as a synthetic biochemical company in the United States. The company develops SimplePath, a platform that produces chemicals, including pharmaceuticals, fuels, materials, food additives, and novel compounds. Its platform also comprises one or more module which consist of one or more enzymes that work together to perform a defined biocatalytic conversion. The company was founded in 2014 and is headquartered in ...
Industry Biotechnology
Sector Healthcare
IPO Date Nov 13, 2024
Employees 29
Stock Exchange NASDAQ
Ticker Symbol IZTC
Website https://www.invizyne.com
Advertisement
5 months ago
Invizyne Technologies shares are trading higher af...
Unlock content with
Pro Subscription